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Background: Surgical patients with preoperative anemia are more likely to experience 
adverse outcomes. Patient blood management (PBM) guidelines recommend screening and 
treating patients for anemia preoperatively to enable optimisation before surgery. This study 
investigates compliance with PBM guidelines and reports the association between length of 
stay and transfusion risk in patients with preoperative anemia.
Study Design and Methods: A retrospective, observational, chart audit that included all 
patients having primary, total hip and knee replacement surgery between July– 
December 2018 at a tertiary, metropolitan healthcare facility.
Results: Six hundred and seven patients patients were included, 96% (n = 583) patients had 
blood tests available (full blood count), and 8.1% (n = 49) had iron studies. Most patients 
53% (n = 324) were screened between 2 and 6 days before surgery; 14.6% (n = 85) were 
anaemic preoperatively and only 5.9% (n = 5) of anaemic patients received treatment. 
Patients who had anemia preoperatively were more likely to receive a blood transfusion 
(odds ratio 8.65 [95% CI 3.98–18.76]) and stayed longer in hospital (median difference = 1, 
χ2 LR = 17.2, df=1, p<0.007).
Conclusion: Tests ordered for patients having major surgery should include iron studies, 
renal function, CRP and full blood count to enable detection and classification of preopera-
tive anemia. Timing of screening relative to surgery needs to be sufficient to allow patient 
optimisation to occur. Appropriate treatment should be provided to anaemic patients to 
prevent unnecessary blood transfusions and reduce the length of stay. A standardised pre-
operative anemia pathway may assist in improving practice.
Keywords: preoperative anemia, patient blood management, surgery
Introduction
Anemia is a condition whereby a person’s blood has impaired oxygen-carrying 
capacity.1 A patient is defined as anaemic, according to the National Blood 
Authority (NBA) Australia, when their hemoglobin is below 130g/L for males 
and 120g/L for non-pregnant females.2 In surgical patients, there is an association 
between preoperative anemia and adverse outcomes, including increased length of 
stay, risk of infection, and risk of receiving a blood transfusion.3
The prevalence of preoperative anemia varies according to patient co- 
morbidities.4 In the colorectal surgical population (where patients may have 
impaired iron absorption), preoperative anemia is present in approximately 36% 
of patients.4 In the orthopaedic surgery population, a recent Australian study found 
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that 13.9% of patients in an elective surgical cohort were 
anaemic.4 These figures mirror the results of another 
Australian, nationwide audit undertaken by Blood 
Matters, Victoria, that found 14% of orthopaedic surgery 
patients to be anaemic.5 These patient groups can be 
responsible for between 42% and 83% of blood transfu-
sions provided to patients postoperatively.3,6 Blood trans-
fusions should be avoided in otherwise healthy 
populations as they are associated with an increased risk 
of infection, coagulopathy and prolonged length of stay.7 
Screening and treatment of anemia can help prevent 
unwarranted blood transfusions.
PBM guidelines outline recommended screening and 
treatment for anemia for patients having major surgery, 
and those at risk of losing >500mLs of blood.2,8-11 
Recommended tests include a Full Blood Count (FBC), 
iron studies, C-reactive Protein (CRP) and renal function.2 
Screening should occur at least six weeks before surgery to 
allow time for treatment to be provided.2 All patients 
detected as having anemia should undergo physician 
review, at which point the cause of the anemia should be 
ascertained and any underlying comorbidities identified.12 
In the case of Iron Deficient Anemia (IDA), oral or IV Iron 
supplementation should be provided.2 Oral supplementa-
tion should be commenced at least 30 days before surgery, 
depending on the level of repletion required.13 Oral supple-
mentation is traditionally poorly tolerated due to the unplea-
sant gastrointestinal side effects, and IV Iron may be more 
suitable in the instance of noncompliance.13
The PBM guidelines now form part of hospital accred-
itation processes.14 Hospitals must ensure that they have 
standardised pathways in place that support clinicians to 
screen and treat patients for anemia.14 Therefore, we sought 
to understand whether we were complying with these recom-
mendations in the context of patients undergoing major joint 
replacement surgery. Within this population, anemia screen-
ing and preoperative optimisation can have a significant 
impact on reducing the length of hospital stay, and the prob-
ability of a patient requiring a blood transfusion.15,16 This 
study reports compliance levels with recommended preo-
perative anemia screening and treatment practices, and the 
impact on blood transfusions and length of stay.17
Materials and Methods
Study Design and Population
A retrospective audit of all patients who underwent total 
hip or knee replacement surgery during Jul–Dec 2018 was 
conducted. We included patients from four campuses 
(three private and one public) of a tertiary healthcare 
facility, in South East Queensland, Australia. The records 
were located by using the Diagnosis Related Group (DRG) 
codes I04A&B (total knee replacements, minor and major 
complexity), and I03A&B (total hip replacement, minor 
and major complexity). We included all patients over the 
age of 18 undergoing primary surgery of this nature. We 
excluded revision surgeries to ensure accurate and consis-
tent measurement of usual preoperative screening and 
treatment processes.
As we included pre-collected patient data, an ethics 
exemption was sought from the Mater Misericordiae Ltd 
Human Research Ethics Committee: EXMT/MML/58392.
Measures
An audit tool was developed by the multidisciplinary team and 
piloted for face validity. Four team members (AD, LG, BH & 
EP) recorded data electronically. The audit tool aimed to 
measure practice against the NBA’s PBM guidelines and 
assessed whether patients were screened for anemia using 
recommended tests. It also recorded the time frame between 
testing and surgery and if patients identified as anaemic 
received appropriate treatment.2 We allowed up to six months 
for tests to be undertaken before surgery and searched for 
FBC, iron studies, CRP, and renal studies. We also collected 
the type of treatment that the patient received including iron 
supplementation (oral or IV) and blood transfusions. We 
assessed all treatment provided for clinical appropriateness 
based on the PBM guidelines2 (see Figure 1).
Decisions of the appropriateness of blood transfusions 
were also based on the additional practice points in the NBA 
Perioperative PBM guidelines.18 The practice points state 
that the decision to transfuse should be made in the context 
of the clinical picture (not just a hemoglobin “trigger”).18 
The patient should demonstrate some form of clinical 
decompensation and the patient should be reassessed 
between transfusion episodes.18 In this study, to determine 
if a transfusion was part of a single or double transfusion 
episode, we checked to see if there was any evidence of 
a physician check or blood test within six-hours following 
the provision of a transfusion. If there was no evidence of 
follow up and two units were provided within six hours, 
they were considered a double unit episode.
Statistical Analysis
Patient characteristics were summarised using count and 
percentages if categorical, and mean and interquartile 
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range for continuous variables. Odds ratios with confi-
dence intervals have been used to determine the risk asso-
ciated with preoperative anemia and receiving a blood 
transfusion. The relationship between preoperative anemia 
and acute length of stay was investigated using Kaplan– 
Meier estimates of the survival (length of hospitalisation) 
curves. A formal comparison of preoperative anemia status 
and length of stay was conducted using the Log Rank test. 
All analysis was conducted in the R statistical software 
(V3.6.1 R core team, 2019), and a significance level of 
0.05 was used throughout all inferential analyses.
Results
Six hundred and seven patients were included. Of these, 
61.3% (n= 372) underwent knee surgery, and 39% (n =235) 
had hip surgery. Overall, 96% (n = 583) patients had a full 
blood count in the six months prior. Only 8.1% (n = 49/607) 
of the patients included had iron studies. Of the patients with 
tests, 14.7% (n = 85) of 583 had preoperative anemia. 
Demographics are outlined in Table 1.
Screening
Almost all patients had a preoperative FBC and renal studies, 
but few had a CRP or iron studies. Only 2.4% (n = 15) of 
patients had all recommended screening required. The com-
pliance with these tests is outlined in Table 2.
The majority of patients did not appear to have timely 
screening, with 3.95% (n = 24) of patients having it conducted 
in the recommended timeframes (6 weeks or more) (Table 3).
Treatment Provided (Iron)
Only 4.3% (n = 26) of patients received iron supplementa-
tion, 38.5% (n = 10) of whom were anaemic prior to surgery. 
Figure 1 Simplified guidance for appropriateness of treatment. 




Male % (n) 44% (267)
Female % (n) 56% (340)
Age - mean (IQR) 67 (13)
Length of time from screening to surgery (median) 2–6 days
Preoperative anemia % (n) 14.6% (85)
Length of stay in hospital, mean (SD) 4 days (SD:1.94)
Hemoglobin - preop (g/L) median (IQR) 138 (18)
Ferritin (microg) (median, IQR)* 120.5 (161.5)
Note: *Patients with ferritin levels (n = 49).
Table 2 Screening Tests Utilised
Screening Tests Total % (n/Total)
FBC % (n) 96% (583)
Iron studies % (n) 8% (49/607)
Renal studies % (n) 94.7% (575/607)
CRP % (n) 2.4% (15)
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Of the anaemic patients who received treatment, 4.7% (n = 4) 
received IV Iron preoperatively, 1.2% (n =1) was taking oral 
iron preoperatively, and 5.9% (n = 5) received IV Iron post-
operatively. Of the non-anaemic patients, 0.8% (n = 4) 
received IV Iron preoperatively, 0.2% (n = 1) received IV 
Iron postoperatively, 1.6% (n = 8) were on oral iron preo-
peratively, 0.4% (n = 2) were discharged on oral iron supple-
mentation. Based on ferritin levels (of which there were 
small numbers), 1.2% (n = 1) received treatment that was 
concordant with guidelines.
Outcomes in Patients with Preoperative 
Anemia
Blood Transfusion
Blood products were provided to 4.8% (n = 29) of patients 
across 40 episodes. The pre-transfusion hemoglobin ran-
ged from 69–110g/L (median 80g/L), however the patient 
with 110g/L was bleeding intraoperatively. 72.5% (n = 29) 
of episodes were single unit transfusion episodes, 27.5% 
(n = 11) were double unit transfusions (with no assessment 
between units). 47.5% (n = 19) episodes were provided 
according to the PBM guidelines, and the remaining 
52.5% (n = 21) were not (16, had no evidence of decom-
pensation, and 5 were due to a lack of evidence of reas-
sessment). Patients with preoperative anemia were at 
a significantly increased risk of receiving a transfusion 
(odds ratio 8.65 [95% CI 3.98–18.76]) and represented 
55% (n = 16) of the 29 patients who received blood.
Length of Stay
The Kaplan–Meier curve in Figure 2 reflects the probabil-
ity of anaemic and non-anaemic patients remaining in 
hospital. Perusal of the curves suggests that there is some 
difference in the acute length of stay between patients with 
and without anemia, and that this difference is statistically 
significant (median difference = 1, χ2 LR = 17.2, df=1, 
p<0.007).
Patients who had preoperative anemia stayed one (1) day 
longer compared to non-anaemic patients (Figure 2). Patients 
treated with a blood transfusion also stayed one day longer, 
on average, than those who did not receive a transfusion 
(IQR 3–7and 3–5, respectively).
Discussion
This study reveals three key findings. The first is that at 
this institution, preoperative anemia screening is not 
occurring according to guidelines both in terms of the 
tests undertaken and the time of which they occur. 
Secondly, patients are not receiving appropriate treatment 
before surgery. Finally, patients with preoperative anemia 
are at a significantly higher risk of receiving a blood 
transfusion and staying longer in hospital.
This audit revealed that the vast majority of patients do 
not have the recommended screening tests. Preoperative 
anemia screening in the setting under study should be 
widened to include iron studies, CRP (to exclude chronic 
inflammatory causes) and renal studies.2 All patients at 
risk of losing >500mLs of blood intraoperatively should 
have the tests ordered as soon as it is decided that surgery 
is required so that their management can be optimised.1 
The fact that the recommended tests are not being carried 
out in the institution under study is likely to be multi-
factorial. Currently, there is no standardised pathway in 
place.6 However, work is currently underway to rectify 
this and the orthopaedic team are already integrating the 
recommendations of this report into their practice.
In addition to the screening requiring improvement, the 
timing of the tests is not adequate to facilitate the optimisa-
tion of patients identified as anaemic before surgery. Most 
patients in this audit had tests 2–6 days before surgery, 
which, in the context of the guidelines, does not leave enough 
time to consider the use of oral supplementation.2 It also does 
not provide an opportunity to provide IV Iron in the currently 
recommend time frames (8 weeks);2 although some small 
studies are showing a benefit of ultra-short-term iron 
therapy.19,20 This presents a potential opportunity to consider 
when developing preoperative anemia treatment pathways. 
A double-blind, randomised, controlled study undertaken by 
Spahn and colleagues in 2019, tested the impact of ultra-short 
-term combination therapy for anaemic patients and found it 
reduced the rate of transfusion.19 The combination included 
IV Iron, subcutaneous erythropoietin alpha, B12 injections 
and oral folic acid.19 When the therapy was provided from 
one to three days before surgery, the median number of 
transfusions per patient was reduced from 1 to 0 (odds ratio 
0.70 [95% CI 0.50–0.98]).19 A similar study found that short- 
term iron and recombinant human erythropoietin therapy 
Table 3 Timeframes of Screening
Time Between Screening and Surgery Total % (n/Total)
Screening 0–1 day % (n/total) 20.1% (122/607)
Screening 2–6 days % (n/total) 53.4% (324/607)
Screening 1–6 weeks % (n/total) 18.6% (113/607)
Screening 6 weeks or greater % (n/total) 3.95% (24/607)
No screening % (n/total) 3.95% (24/607)
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given 2–5 days preoperatively, reduced blood transfusion 
rates from 48.8% to 32.4% (P = 0.001).20 These studies 
suggest that current guidelines may need to be revised, and 
short-term treatment may be a viable option if necessary for 
urgent, non-elective cases.
The second finding was that anemia is not routinely 
corrected. Only 10 of the 85 patients identified as anaemic 
had some form of preoperative treatment. Studies have 
shown that preoperative optimisation can reduce the num-
ber of blood transfusions provided in this population.17 
Rineau and colleagues implemented a preoperative anemia 
pathway and found a significant reduction in the amount of 
blood transfusions required where anemia was corrected 
(13% non-corrected vs 5% corrected), consistent with the 
results of our previous audits.6 Had patients been screened 
and treated in a timely fashion, they may have avoided 
transfusion.
The final finding was that patients who were anaemic 
before surgery were more likely to receive a transfusion 
and have longer hospital stays. Our results show that 
patients who were anaemic stayed one day longer than 
those who were not (median difference = 1, χ2 LR = 17.2, 
df=1, p<0.007) and were also more likely to receive 
a transfusion (odds ratio 8.65 [95% CI 3.98–18.76]). 
These results mirror trends between preoperative anemia, 
blood transfusions and length of stay reported in the 
literature.21,22 A recent retrospective cohort study con-
ducted in 2019 that included 1186 patients demonstrated 
that those with preoperative anemia were more likely to 
receive a blood transfusion 13.1% versus 0.7% (OR 21.7 
(2.9–166.7, P<0.001)) in non-anaemic patients.21 They 
also found that patients with preoperative anemia stayed 
longer in hospital (3 days compared to 2.1 (P=0.006)) and 
had increased infectious complications (from 6.4% to 
18.4%, (OR 3.3 (1.4–7.7), p=0.004)).21 Another 2017 
cohort study including cardiac patients had similar find-
ings. Patients who were anaemic preoperatively were three 
times more likely to receive a blood transfusion (OR 3.08, 
Figure 2 Kaplan–Meier survival curve: length of stay difference between patients who were anaemic and non-anaemic preoperatively.
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95% CI 1.88–5.06, p < 0.001) and remained in hospital 
two days longer (8 vs 6 days, p < 0.0001).22 It is therefore 
important that steps are undertaken to prevent exposing 
surgical patients to unnecessary risks.
Development of standardised anemia screening and 
treatment pathways can help reduce variation in care and 
prevent unnecessary exposure to blood products. 
Implementation of such a pathway has demonstrated suc-
cess in improving compliance with PBM guidelines.23 
Morgan and colleagues undertook a “before and after” 
study in a private orthopaedic setting and improved both 
screening and treatment practices.16 Following implemen-
tation, they achieved a result of 94.6% (P<0.0001) of 
patients receiving required tests and reduced blood trans-
fusions from 9.2% to 2.3% (P=0.001).16 Another example 
of this is reflected in a study that demonstrated 
a significant decrease from 20.8% to 14.4% (P = 0.001) 
over six years in anaemic admissions following the imple-
mentation of a preoperative anemia screening and treat-
ment pathway.24 This study also detailed product-related 
cost savings of $18,507,092 AUD and up to $100 million 
when activity-based costs were factored in (over the six- 
year period).24 Similarly, Faulds and colleagues found 
decreased transfusion rates in patients who were treated 
according to a preoperative anemia pathway (17.4% versus 
9.2%).3 Locally, significant progress has been made to 
develop a pathway. However, it has not been without 
challenges in the context of a facility that includes both 
public and private patients. Morgan and colleagues shared 
some of the challenges, including the care needed to 
navigate developing a pathway without dictating terms to 
private practitioners, who often have greater autonomy 
than their public colleagues.16 Continued work to develop 
locally agreed procedures that is underpinned by contem-
porary implementation theory is ongoing, but the uptake of 
these recommendations has already commenced within the 
orthopaedic team.
This study has limitations due to the retrospective nature 
of the data collection. We were unable to ascertain the 
specific type of anemia due to a lack of test results. The 
study is also limited to information documented in charts 
and blood results across multiple pathology providers. We 
could not guarantee that the general practitioner responsible 
for referring the patient had not previously identified the 
issue and treated the patient before the time of surgery. It is 
also difficult to comment on the appropriateness of blood 
transfusions, as clinical notes and observation charts were 
relied upon to assist in deciding whether the transfusion was 
provided according to guidelines. A prospective study 
design would be useful to ascertain more accurate trends 
in patients who have demonstrated preoperative anemia. 
A strength of the study is the large sample size.
All patients undergoing major surgery with a risk of 
blood loss >500mLs should be screened in advance for 
anemia by having a full blood count, iron studies, CRP and 
renal studies, regardless of the presence of comorbidities 
or a trigger during the preoperative assessment phase. 
Hospitals should develop pathways that consider the 
local context and the patient population. Further research 
that rigorously reports on the development of preoperative 
anemia screening pathways using implementation theory 
and the effect of those pathways are required to help 
advance the knowledge of how to achieve this.
Where patients are due for urgent surgery, they should 
be referred to an established IV Iron infusion clinic to 
enable optimisation for surgery.2 If the patient’s surgery is 
not booked within 30 days, oral supplementation is recom-
mended as the first-line treatment option. Postoperatively, 
caution is needed when deciding to provide a blood transfu-
sion, as the benefits must outweigh the risks. In healthy 
patients, a transfusion is likely to be unwarranted.
Conclusion
Preoperative anemia in this setting is an important condi-
tion to screen and treat to optimise a patient’s iron stores 
and reduce the risk associated with exposure to blood 
transfusions and prolonged length of stay. The facility 
under study will continue the process to establish standar-
dised pathways that are context-specific and developed 
with the multidisciplinary team to support the implemen-
tation of the PBM guidelines.
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